首页> 外国专利> Compound, pharmaceutical composition, agent to control retinoid-related receptors, diabetes mellitus prevention and therapy processes, hyperlipemia prevention and therapy, to enhance insulin sensitivity, to improve insulin resistance, prevention and therapy of impaired glucose tolerance, prevention and therapy of an inflammatory disease, prevention of arterial sclerosis, and, use of the compound

Compound, pharmaceutical composition, agent to control retinoid-related receptors, diabetes mellitus prevention and therapy processes, hyperlipemia prevention and therapy, to enhance insulin sensitivity, to improve insulin resistance, prevention and therapy of impaired glucose tolerance, prevention and therapy of an inflammatory disease, prevention of arterial sclerosis, and, use of the compound

机译:化合物,药物组合物,控制类维生素A相关受体的药物,糖尿病的预防和治疗过程,高脂血症的预防和治疗,增强胰岛素敏感性,改善胰岛素抵抗,糖耐量降低的预防和治疗,炎性疾病的预防和治疗,预防动脉硬化和使用该化合物

摘要

"COMPOSITE, PHARMACEUTICAL COMPOSITION, AGENT TO CONTROL RETINOID-RELATED RECEPTORS, DIABETES MELLITUS PREVENTION AND THERAPY PROCESSES, PREVENTION AND THERAPY OF HYPERLIPEMIA, TO ACCOMPLISH A INSULIN SENSITIVITY, IMPROVEMENT, IMPROVEMENT OF INSULIN, IMPROVEMENT FROM TOLERANCE TO HARMED GLUCOSE, PREVENTION AND THERAPY FOR AN INFLAMMATORY DISEASE, PREVENTION AND THERAPY FOR AN ARTERIAL SCLEROSIS, AND, USE OF THE COMPOUND "To provide a new derivative of oxyiminoalkanoic acid that has excellent hypoglycemic and hypolidemic actions to be used for hypoglycemic and hypolipidemic and hypolipidemic and hypolipidemic actions. prevention or treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance and impaired glucose tolerance. A compound represented by formula (a) in which R¹ is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is a bond, -CO-, -CH (OH) - or a group represented by -NR ^ 6 ^ - where R ^ 6 ^ is a hydrogen atom or an optionally substituted alkyl group; n is an integer from 1 to 3; Y is an oxygen atom, a sulfur atom, -SO-, -SO ~ 2 ~ - or a group represented by -NR ^ 7 ^ - where R ^ 7 ^ is a hydrogen atom or an alkyl group optionally; ring A is a benzene ring optionally having one to three additional substituents; p is an integer from 1 to 8; R ~ 2 ~ is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; q is an integer from 0 to 6; m is 0 or 1; R³ is a hydroxy group, OR ^ 8 ^ (R ^ 8 ^ is an optionally substituted hydrocarbon group) or NR ^ 9 ^ R ^ 10 ^ (R ^ 9 ^ and R ^ 10 ^ are the same or different groups that are selected from a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group or R ^ 9 ^ and R ^ 10 ^ combine together to form a ring); R ^ 4 ^ and R ^ 5 ^ are the same groups or different groups that are selected from a hydrogen atom or from an optionally substituted hydrocarbon group in which R ^ 4 ^ can form a ring with R ^ 2 ^; provided that when R¹ is an ethoxymethyl, a C ~ 1-3 ~ alkyl, phenyl or p-methoxyphenyl and q = m = 0, R³ is NR ^ 9 ^ R ^ 10 ^; and as long as O- [2-chloro-4- (2-quinolylmethoxy) phenylmethyl] oxime and a methyl pyruvate of [2-chloro-4- (2-quinolylmethoxy) phenylmethyl-2-iminoxypropionic acid are excluded; or a salt like this.
机译:“复合物,药物成分,控制与类视黄醇有关的受体,糖尿病预防和治疗过程,高脂血症的预防和治疗的复合药物成分,以改善胰岛素的敏感性,改善,改善和改善动脉硬化的炎症性疾病,预防和治疗,以及该化合物的使用“提供一种具有优异降血糖和降血脂作用的氧亚氨基链烷酸的新衍生物,可用于降血糖和降血脂以及降血脂和降血脂作用。预防或治疗糖尿病,高血脂,胰岛素不敏感,胰岛素抵抗和糖耐量降低。由式(a)表示的化合物,其中R 1是任选取代的烃基或任选取代的杂环基; X为键,-CO-,-CH(OH)-或-NR ^ 6 ^-表示的基团,其中R ^ 6 ^为氢原子或任选取代的烷基; n为1至3的整数; Y为氧原子,硫原子,-SO-,-SO〜2〜-或-NR ^ 7 ^-表示的基团,其中R ^ 7 ^为氢原子或烷基。环A为苯环,其任选具有1-3个另外的取代基; p是1至8的整数; R 2-为氢原子,任选取代的烃基或任选取代的杂环基; q是0到6之间的整数; m为0或1; R 3是羟基,或OR ^ 8 ^(R ^ 8 ^是任选取代的烃基)或NR ^ 9 ^ R ^ 10 ^(R ^ 9 ^和R ^ 10 ^是相同或不同的基团由氢原子,任选取代的烃基,任选取代的杂环基或任选取代的酰基或R ^ 9 ^和R ^ 10 ^结合在一起形成环); R ^ 4 ^和R ^ 5 ^是选自氢原子或任选取代的烃基的相同基团或不同基团,其中R ^ 4 ^可与R ^ 2 ^形成环;前提是当R 1是乙氧基甲基,C〜1-3〜烷基,苯基或对甲氧基苯基且q = m = 0时,R 3为NR ^ 9 ^ R ^ 10 ^;只要不包括O- [2-氯-4-(2-喹啉基甲氧基)苯甲基]肟和丙酮酸甲酯[2-氯-4-(2-喹啉基甲氧基)苯基甲基-2-亚氨氧基丙酸];或像这样的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号